Charles River Laboratories Operating Expenses 2010-2024 | CRL

Charles River Laboratories annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Charles River Laboratories operating expenses for the quarter ending June 30, 2024 were $0.874B, a 2.29% decline year-over-year.
  • Charles River Laboratories operating expenses for the twelve months ending June 30, 2024 were $3.516B, a 0.42% decline year-over-year.
  • Charles River Laboratories annual operating expenses for 2023 were $3.512B, a 5.63% increase from 2022.
  • Charles River Laboratories annual operating expenses for 2022 were $3.325B, a 12.7% increase from 2021.
  • Charles River Laboratories annual operating expenses for 2021 were $2.95B, a 18.43% increase from 2020.
Charles River Laboratories Annual Operating Expenses
(Millions of US $)
2023 $3,512
2022 $3,325
2021 $2,950
2020 $2,491
2019 $2,270
2018 $1,935
2017 $1,569
2016 $1,444
2015 $1,157
2014 $1,120
2013 $1,014
2012 $964
2011 $968
2010 $1,432
2009 $1,002
Charles River Laboratories Quarterly Operating Expenses
(Millions of US $)
2024-06-30 $874
2024-03-31 $886
2023-12-31 $881
2023-09-30 $875
2023-06-30 $895
2023-03-31 $861
2022-12-31 $936
2022-09-30 $838
2022-06-30 $786
2022-03-31 $765
2021-12-31 $732
2021-09-30 $740
2021-06-30 $777
2021-03-31 $701
2020-12-31 $662
2020-09-30 $611
2020-06-30 $606
2020-03-31 $613
2019-12-31 $582
2019-09-30 $575
2019-06-30 $578
2019-03-31 $535
2018-12-31 $499
2018-09-30 $501
2018-06-30 $509
2018-03-31 $426
2017-12-31 $416
2017-09-30 $390
2017-06-30 $387
2017-03-31 $376
2016-12-31 $398
2016-09-30 $367
2016-06-30 $376
2016-03-31 $303
2015-12-31 $302
2015-09-30 $294
2015-06-30 $284
2015-03-31 $277
2014-12-31 $289
2014-09-30 $281
2014-06-30 $290
2014-03-31 $260
2013-12-31 $265
2013-09-30 $251
2013-06-30 $250
2013-03-31 $248
2012-12-31 $245
2012-09-30 $241
2012-06-30 $235
2012-03-31 $242
2011-12-31 $249
2011-09-30 $240
2011-06-30 $235
2011-03-31 $244
2010-12-31 $647
2010-09-30 $264
2010-06-30 $259
2010-03-31 $262
2009-12-31 $230
2009-09-30 $253
2009-06-30 $257
2009-03-31 $262
Sector Industry Market Cap Revenue
Medical Medical Services $11.285B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00